Literature DB >> 21570115

Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis?

U Manuelpillai1, Y Moodley, C V Borlongan, O Parolini.   

Abstract

In addition to the placenta, umbilical cord and amniotic fluid, the amniotic membrane is emerging as an immensely valuable and easily accessible source of stem and progenitor cells. This concise review will focus on the stem/progenitor cell properties of human amniotic epithelial and mesenchymal stromal cells and evaluate the effects exerted by these cells and the amniotic membrane on tissue inflammation and fibrosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21570115     DOI： 10.1016/j.placenta.2011.04.010

Source DB:  PubMed          Journal:  Placenta        ISSN： 0143-4004            Impact factor:   3.481


  47 in total

1.  Stroke therapy: the potential of amniotic fluid-derived stem cells.

Authors:  Maya Elias; Jaclyn Hoover; Hung Nguyen; Stephanny Reyes; Christopher Lawton; Cesar V Borlongan
Journal:  Future Neurol       Date:  2015

2.  Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs.

Authors:  Yong Qiang; Guiyou Liang; Limei Yu
Journal:  Lab Invest       Date:  2016-02-29       Impact factor: 5.662

3.  A novel combination of homeobox genes is expressed in mesenchymal chorionic stem/stromal cells in first trimester and term pregnancies.

Authors:  Haiying Liu; Padma Murthi; Sharon Qin; Gina D Kusuma; Anthony J Borg; Martin Knöfler; Peter Haslinger; Ursula Manuelpillai; Mark D Pertile; Mohamed Abumaree; Bill Kalionis
Journal:  Reprod Sci       Date:  2014-04-01       Impact factor: 3.060

Review 4.  Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.

Authors:  Jia-Wen Si; Xu-Dong Wang; Steve Gf Shen
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord.

Authors:  Mingjun Wu; Ruifan Zhang; Qing Zou; Yaoyao Chen; Min Zhou; Xingjie Li; Ran Ran; Qiang Chen
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

Review 6.  Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Authors:  Jan H Spaas; Deborah J Guest; Gerlinde R Van de Walle
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

7.  Regenerative Effects of Hypoxia Primed Flowable Placental Formulation in Muscle and Dermal Injury.

Authors:  Sandeep Dhall; Min Sung Park; Chaoyang Li; Malathi Sathyamoorthy
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  Human Amnion-Derived Mesenchymal Stromal Cells in Cirrhotic Patients with Refractory Ascites: A Possible Anti-Inflammatory Therapy for Preventing Spontaneous Bacterial Peritonitis.

Authors:  Mariangela Pampalone; Simona Corrao; Giandomenico Amico; Giampiero Vitale; Rossella Alduino; Pier Giulio Conaldi; Giada Pietrosi
Journal:  Stem Cell Rev Rep       Date:  2021-01-03       Impact factor: 5.739

9.  Intravenous Administration of Human Amniotic Mesenchymal Stem Cells in the Subacute Phase of Cerebral Infarction in a Mouse Model Ameliorates Neurological Disturbance by Suppressing Blood Brain Barrier Disruption and Apoptosis via Immunomodulation.

Authors:  Yasunori Yoshida; Toshinori Takagi; Yoji Kuramoto; Kotaro Tatebayashi; Manabu Shirakawa; Kenichi Yamahara; Nobutaka Doe; Shinichi Yoshimura
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

10.  Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.

Authors:  Naoki Tajiri; Sandra Acosta; Loren E Glover; Paula C Bickford; Alejandra Jacotte Simancas; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.